Cell Biosciences Raises $10M in Private Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Cell Biosciences has raised $10 million through a Series C private financing, the Palo Alto, Calif.-based firm said today.

The company has developed an "ultrasensitive" nanofluidic immunoassay system designed to analyze proteins in very small biological samples. It said researchers can use the system to discover details about phosphoprotein signaling in a wide variety of biological systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.